Who
Mats Wahlstrom
Director
Company insider
Files Form 4 as: Director, Coherus Oncology; Director and 10% owner, TriSalus Life Sciences; Director, Health Grades.
In numbers
- Trades disclosed
- 80
- Buys
- 4
- Sells
- 9
- Bought
- $373K
- Sold
- $12.0M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 1 Apr 2009
- Last trade
- 5 Jun 2026
- Last filed
- 9 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 9 Jun 2026 | CHRS Coherus OncologyBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | CHRS Coherus Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | CHRS Coherus Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | CHRS Coherus OncologyBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $152K60,000 at $2.53 | filing |
| 15 May 2026filed 18 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $152K60,000 at $2.53 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —37,602 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —34,226 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —75,204 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —75,204 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —37,602 at $0.00 | filing |
| 14 May 2026filed 15 May 2026 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | —34,226 at $0.00 | filing |
| 12 Jun 2025filed 27 Jun 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 12 Jun 2025filed 13 Jun 2025 | CHRS Coherus Oncologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —112,000 at $0.00 | filing |
| 23 May 2025filed 28 May 2025 | CHRS Coherus OncologyBiotechnology | SEC FORM 4 Sold | $74K99,988 at $0.74 | filing |
| 10 Feb 2025filed 11 Feb 2025 | TLSI TriSalus Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code J | —44,750 at $0.00 | filing |
| 17 Dec 2024filed 19 Dec 2024 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Code A | $100K25,188 at $3.97 | filing |
| 22 Nov 2024filed 25 Nov 2024 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $23K5,000 at $4.55 | filing |
| 21 Nov 2024filed 22 Nov 2024 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $39K8,687 at $4.44 | filing |
| 20 Nov 2024filed 22 Nov 2024 | TLSI TriSalus Life SciencesMedical Devices | SEC FORM 4 Bought | $8,4862,040 at $4.16 | filing |
News
Reviewing TriSalus Life Sciences (NASDAQ:TLSI) and Brainsway (NASDAQ:BWAY)TLSI · themarketsdaily.com · 21 Oct 2026Financial Comparison: Brainsway (NASDAQ:BWAY) and TriSalus Life Sciences (NASDAQ:TLSI)TLSI · dailypolitical.com · 14 Oct 2026TriSalus Life Sciences, Inc. (TLSI) – What Are Brokerages Saying About This Stock?TLSI · dailypolitical.com · 11 Oct 2026
0 headlines in the last 90 days name Mats Wahlstrom; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.